Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a safety, pharmacokinetics, and pharmacodynamics study of BMS-830216 in obese subjects (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BMS-830216

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obesity | Phase 1, Phase 2 | Status: COMPLETED